Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S Goodyear, MC Sharma - Experimental and molecular pathology, 2007 - Elsevier
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …
被引用次数：125 相关文章

[引用][C] Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S Goodyear, MC Sharma - Experimental and Molecular Pathology, 2007 - cir.nii.ac.jp
Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival
through cell cycle regulatory protein cdk5 | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S Goodyear, MC Sharma - Experimental and …, 2007 - researchdiscovery.drexel.edu
Biological and medical sciences Gynecology. Andrology. Obstetrics Investigative
techniques, diagnostic techniques (general aspects) Mammary gland diseases Medical …
[PDF] researchgate.net

[PDF][PDF] Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5☆

S Goodyear, MC Sharma - Experimental and Molecular Pathology, 2007 - researchgate.net
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …

[引用][C] Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S GOODYEAR, MC SHARMA - Experimental and molecular …, 2007 - pascal-francis.inist.fr
Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival
through cell cycle regulatory protein cdk5 CNRS Inist Pascal-Francis CNRS Pascal and …

Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S Goodyear, MC Sharma - Experimental and Molecular Pathology, 2007 - infona.pl
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …

Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S Goodyear, MC Sharma - Experimental and molecular …, 2007 - pubmed.ncbi.nlm.nih.gov
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …

Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.

S Goodyear, MC Sharma - Experimental and Molecular Pathology, 2006 - europepmc.org
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …

Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

S Goodyear, MC Sharma - Experimental and Molecular …, 2007 - ohsu.elsevierpure.com
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …
[PDF] academia.edu

[PDF][PDF] Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein...

S Goodyear, M Sharma - Experimental and Molecular Pathology, 2007 - academia.edu
Roscovitine, a purine analogue, has been considered for the treatment of cancer. Anti-
cancer therapeutic efficacy is being evaluated in clinical trials. However, the mechanisms …